The phorbol ester 12-O-tetradecanoylphorbol 13-acetate induces tumour promotion, inflammation, cell proliferation and prostaglandin release. Recent reports suggest that the prostaglandins released by 12-O-tetradecanoylphorbol 13-acetate (TPA) initiate a cascade of events leading to polyamine synthesis and cell proliferation. In experiments designed to test this contention, it was found that addition of TPA (1I M to 1 nM) to confluent mouse 3T3 fibroblasts successively caused the release of prostaglandins E2 and I2, induction of the enzyme ornithine decarboxylase (EC 4.1.1.17), stimulation of [3Hlthymidine incorporation into DNA, and cell proliferation. Pretreatment of the cells with the anti-inflammatory steroid dexamethasone (1IUM) or the non-steroidal anti-inflammatory drug indomethacin (1 M) inhibited TPA-induced prostaglandin release. However, dexamethasone enhanced the other effects of TPA, whereas indomethacin was ineffective. Addition of prostaglandin E2 to the cultures did not induce ornithine decarboxylase activity and cell proliferation. Pretreatment of the cells with 1,3-diaminopropane (1 mM) or a-methylornithine (5mM), inhibitors of polyamine synthesis, decreased TPA-induced ornithine decarboxylase activity without affecting DNA synthesis. TPA stimulated [3Hlthymidine incorporation into DNA, even when the ornithine decarboxylase activity was completely blocked. These data suggest that the proliferative effect of TPA on 3T3 cells is independent of prostaglandin release and polyamine synthesis.
Many macrocyclic diterpene esters possess tumour-promoting activity (Hecker & Schmidt, 1974) . These agents do not themselves induce cancer, but markedly enhance the formation of skin tumours when repeatedly applied to mouse skin pretreated with low doses of chemical carcinogens (Van Duuren, 1969) . The most potent tumour promoter of this group is 12-O-tetradecanoylphorbol 13-acetate. It is the active constituent of croton oil obtained from Croton tiglium seeds (Hecker, 1968) . The tumour-promoting activity of TPA has been determined in a two-stage mouse skin carcinogenesis system developed by Berenblum (1975) .
Phorbol esters also elicit a variety of biological effects in many different cell types in vivo and in vitro. These effects include enhanced cell growth (Sivak, 1977) and biochemical changes such as the induction of ornithine decarboxylase (L-ornithine carboxy-lyase, EC 4.1.1.17), which is the rateAbbrviation used: TPA, 12-0-tetradecanoylphorbol 13-acetate. limiting enzyme in polyamine formation (Yuspa et al., 1976) . TPA also causes inflammation (Hecker, 1971) and alterations in cellular morphology (Sivak, 1977; Brune et al., 1978; Lowe et al., 1978; Ohuchi & Levine, 1978) connected with prostaglandin release in vitro (Brune et al., 1978; Ohuchi & Levine, 1978; Yamasaki et al., 1979) and in vivo (Ashendel & Boutwell, 1979; Fiirstenberger & Marks, 1980) .
The importance of inflammation-related cell proliferation for tumour promotion has been studied extensively, but remains unclear (Belman & Troll, 1972; Scribner & Boutwell, 1972; Scribner & Slaga, 1973; Brune et al., 1978; Slaga et al., 1978; Weeks & Slaga, 1979) . Recent studies have suggested that prostaglandins released by inflammagens may initiate cell proliferation, which will then allow for the expression of malignant cell transformation (Verma et al., 1977 (Verma et al., , 1980 Fiirstenberger & Marks, 1978 ; Ashendel & Boutwell, 1979) .
In the present study we investigated if indeed TPA-induced [5,6,8,11,12,14,15(n) ethanol for use in cell cultures. The concentration of dimethyl sulphoxide or ethanol in the culture medium never exceeded 0.5%.
Determination ofprostaglandin release
Prostaglandin E2 was measured directly in the culture fluid by a specific radioimmunoassay described before (Glatt et al., 1974) . Prostaglandin 12 was measured by a specific radioimmunoassay of the stable hydration metabolite 6-oxoprostaglandin Fil as described by Peskar et al. (1979) .
Determination ofornithine decarboxylase activity
Ornithine decarboxylase activity was determined by measuring the release of "CO2 from L-[ 1-'4Clornithine according to the method of Russell & Snyder (1968) . The cells were scraped off the 60mm dishes at indicated times after treatment and subsequently disrupted by freezing and thawing in 0.3ml of 50mM-sodium phosphate/potassium phosphate buffer, pH 7.2, containing 5 mM-dithiothreitol and 0.2mM-pyridoxal 5'-phosphate. Extracts were then centrifuged at 12 0OOg for 30 min and ornithine decarboxylase activity was measured in the supernatant fluids. The enzyme reaction was performed in 10ml centrifuge tubes equipped with a rubber stopper supporting a centre well of polyethylene (Kontes Glass Co., Vineland, NJ, U.S.A.) containing 0. culture dish for I h. The cells were then washed three times with cold phosphate-buffered saline, scraped off the dishes and disrupted by freezing and thawing in 0.3 ml of phosphate-buffered saline. DNA was extracted and assayed fluorimetrically with 3,5-diaminobenzoic acid as described (Cattolico & Gibbs, 1975; Puzas & Goodman, 1978) . 13Hl-Thymidine incorporation into DNA was determined by measuring radioactivity in a portion of the extract.
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Mechanisms of tumour-promoter effects Determination ofcell proliferation Cells were trypsin-treated and portions of the cell suspension were counted in a Coulter counter.
Results
Effects of TPA on prostaglandin release, ornithine decarboxylase induction and cell proliferation TPA at concentrations of 1 ,UM to 1 nm produced a dose-dependent release of prostaglandin E2 and prostaglandin I2, which reached a maximum 2h after TPA treatment (results not shown). The maximal amount (mean+ S.D.) of prostaglandin E2 released by TPA was 12.92 + 0.97 ng/ml of culture fluid (control 2.69 + 0.55 ng/ml), and the concentration of prostaglandin 12 was 0.80 + 0.03 ng/ml (control 0.1 1 + 0.01 ng/ml). TPA also markedly increased ornithine decarboxylase activity at the same concentrations at which prostaglandin release occurred (Fig. 1) . The ornithine decarboxylase-inducing potency of TPA was most pronounced at day 4 after plating, at which stage the cells had just reached confluency (Fig. 2) . Peak activity of ornithine decarboxylase was found 4 h after TPA treatment, i.e. shortly after the prostaglandin release had reached its maximum (Fig. 3) . Incorporation of 0.1,uM-TPA the maximum being at 18 h after TPA addition (Table 1) . Also, addition of 0.1 pM-TPA increased the cell number per culture significantly within 2 days after treatment (Fig. 4) of ornithine decarboxylase activity by 10mM-1,3-diaminopropane resulted in a decrease of TPAstimulated thymidine incorporation by 60%. Nevertheless, TPA induced DNA synthesis in the total absence of measurable ornithine decarboxylase activity (Fig. 5) . Similar results were obtained with a competitive inhibitor of ornithine decarboxylase activity, a-methylornithine (5mM). This compound decreased TPA-induced ornithine decarboxylase activity by more than 60% when measured in extracts of pretreated cells without affecting TPAstimulated DNA synthesis. No correlation was found between TPA-induced ornithine decarboxylase activity and thymidine incorporation into DNA when the synthesis or activity of ornithine decarboxylase was blocked by inhibitors.
Discussion
The studies described show that TPA triggers a cascade of events in 3T3 cells, leading from prostaglandin production to ornithine decarboxylase activation, followed by thymidine incorporation into DNA and cell proliferation. This chain of events does not appear to consist of causally connected links, in that we did not find evidence that the preceding step, e.g. prostaglandin production, initiates the following one, i.e. ornithine decarboxylase activation. We regard these findings as the main points emerging from our studies.
First, we have produced evidence that metabolic products of arachidonate, i.e. prostaglandins, are not required for the expression of cell proliferation in 3T3 cells as proposed for epidermal cells by Furstenberger & Marks (1980) . We have shown that TPA-induced ornithine decarboxylase activation, thymidine incorporation into DNA and cell proliferation proceed despite inhibition of prostaglandin synthesis. Moreover, prostaglandins, even in pharmacological concentrations (10mM), could not mimic the effects of TPA in 3T3 cells. This is in Vol. 194 with 1 mm-1,3-diaminopropane, which inhibits the synthesis of the enzyme. At this concentration, however, TPA-stimulated thymidine incorporation into DNA was not affected. Complete suppression 979 contrast with findings of other workers. Fiirstenberger & Marks (1978) observed an inhibition of TPA-induced cell proliferation in mouse epidermis by non-steroidal inhibitors of prostaglandin synthesis at high doses (1-10mM-indomethacin). Hial et al. (1977) made similar observations with rat hepatoma cells or human fibroblasts in culture. At high concentrations inhibitors of prostaglandin synthesis have many pharmacological actions (Flower, 1974) . It appears therefore possible that the effects observed by these authors may be unrelated to inhibition of prostaglandin synthesis. This interpretation is supported by the observation that indomethacin is a potent inhibitor of tumour growth (Hial et al., 1976) , an effect apparently unrelated to prostaglandin-synthesis inhibition (De Mello et al., 1980) . The apparent lack of importance of prostaglandins in TPA-stimulated cell proliferation is further supported by the observation that dexamethasone, despite inhibiting prostaglandin synthesis, enhances ornithine decarboxylase activation and cell proliferation after TPA administration. Glucocorticoids decrease the availability of arachidonate for further metabolism (Gryglewski et al., 1975; Flower & Blackwell, 1979) and hence decrease the formation of eicosanoids other than prostaglandins, e.g. lipoxygenase products (Hamberg & Samuelsson, 1974; Nugteren, 1975) . These data exclude the possibility that other eicosanoids not measured in the present study function as mediators in the TPA-stimulated proliferation of 3T3 cells. The observed small but definite enhancing effect of dexamethasone on DNA synthesis and cell proliferation is in agreement with other reports (Thrash & Cunningham, 1973; Clark & Duffy, 1976) , and the attempts to explain this phenomenon are numerous. For example, one could argue that the increase in cell number by dexamethasone is due to better adhesion of the cells to the dish arising from increased production of collagen (Furcht et al., 1979) . But TPA enhances cell proliferation in the presence of inhibited collagen production (Delclos & Blumberg, 1979) . Hence, both effects should antagonize each other. Also this interpretation leaves the increased DNA synthesis unexplained. All these observations are in contrast with the effects of glucocorticoids in vivo, where these compounds inhibit TPA-induced tumour promotion (Belman & Troll, 1972) . Further studies designed to imitate the complex cell-cell interactions likely to occur in vivo are required to clarify this contradiction.
Like prostaglandins, cyclic nucleotides have often been proposed as important growth-regulating messengers (Sheppard & Bannai, 1974) . However, they do not appear to play a major role in the expression of TPA-induced cell proliferation, since a single application of TPA has been found by others to be ineffective in changing the basal cyclic nucleotide concentration (Mufson et al., 1977a; Belman et al., 1978) . Moreover, increasing the concentrations of cyclic nucleotides by ,I-adrenergic drugs had no effect on TPA-induced ornithine decarboxylase activation (Mufson et al., 1977b) . From these results it is likely that cyclic nucleotides can be excluded as possible second messengers in TPA-induced cell proliferation.
On the other hand, polyamines released intracellularly by enhanced ornithine decarboxylase activity have been suggested to function as triggers of TPA-stimulated DNA synthesis in vitro (Yuspa et al., 1976) and in vivo (O'Brien et al., 1975) . We have also tried to discover whether ornithine decarboxylase activation is a necessary step in TPAinduced proliferation of 3T3 cells. By using an inhibitor of ornithine decarboxylase synthesis (1,3-diaminopropane; Poso & Jiinne, 1976; Sunkara et al., 1977) and a competitive inhibitor of ornithine decarboxylase activity (a-methylornithine; AbdelMonem et al., 1975) we found that (a) TPA-induced DNA synthesis proceeded in the absence of measurable ornithine decarboxylase activity (being blocked by 10mM-1,3-diaminopropane). This concentration of 1,3-diaminopropane, however, decreased the TPAinduced thymidine incorporation into DNA by about 60%. This effect is likely to be unspecific since 1,3-diaminopropane at 1 mm decreased the TPAinduced ornithine decarboxylase activity by 80% without affecting the TPA-stimulated DNA synthesis at all. The lack of correlation between ornithine decarboxylase activity and DNA -synthesis does not appear to be due to substitution of the polyamine requirement of the cells by the unphysiological diamine repressor, since similar results were obtained with (b) a-methylornithine. Again, TPA-induced thymidine incorporation proceeded uninhibited in the presence of 5 mM-a-methylornithine, a concentration that is likely to suppress the ornithine decarboxylase activity in intact cells completely (Mamont et al., 1976) . These results clearly argue against an obligatory role of ornithine decarboxylase activation in TPA-induced cell proliferation as suggested by O'Brien et al. (1975) . They are, however, in agreement with the observations of Clark & Duffy (1976) , who found a poor correlation between increases in ornithine decarboxylase activity and DNA synthesis or proliferation of 3T3 cells stimulated by different growth factors.
In conclusion, we have shown that the tumour promoter TPA does not exert its cell-proliferative effect in 3T3 cells via prostaglandin production and ornithine decarboxylase activation, because thymidine incorporation after exposure of these cells proceeds almost uninhibited after total blockade of both biochemical events. The question remains, which messengers, if any, trigger cell proliferation subsequent to TPA administration. Two possi-1981 bilities are worth mentioning in this context. Recently, evidence was produced that the cytoskeleton might play a role in mediating cell proliferation induced by growth factors (Otto et al., 1979) . This suggestion appears attractive since TPA enters the cell interior almost instantaneously (Brune et al., 1979) and changes the cell morphology of macrophages within minutes (Brune et al., 1978) and of 3T3 cells within hours (Sivak, 1977) . However, quantitative morphological studies correlating TPAinduced morphological changes with cell proliferation have yet to be produced. Also, TPA is known to initiate the release of the serine proteinase plasminogen activator. This enzyme appears to be involved in the malignant transformation of cells in culture subsequent to TPA exposure (Wigler & Weinstein, 1976) . It may also lead to enhanced cell proliferation as shown for other proteinases (Noonan & Burger, 1973) . This contention is probably irrelevant to the present study, since TPA-induced secretion of plasminogen activator takes about a day for full expression (Miskin et al., 1978) , which is longer than the time period between TPA addition and the maximum of thymidine incorporation. Nevertheless, the role of TPA-induced secretion of proteinases may contribute to cell proliferation at later times after TPA addition and hence requires further investigation.
